purpose of this study to investigate expression of bcl-2 protein in 111 human breast
carcinomas using immunohistochemistry and the monoclonal antibody bcl-2 124.
Expression was then compared with the established indicators of prognosis and biological
behaviour in malignant breast disease. No relationship could be observed between bcl-2
and node status, tumour size, differentiation, type or age at excision. However, a strong …